Next Article in Journal
The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism
Next Article in Special Issue
A Comparative Study of Black and White Allium sativum L.: Nutritional Composition and Bioactive Properties
Previous Article in Journal
The Versatile Applications of DES and Their Influence on Oxidoreductase-Mediated Transformations
Previous Article in Special Issue
Anti-Inflammatory Compounds from Atractylodes macrocephala
Open AccessArticle

In Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes

1
Department of Plant and Soil Sciences, University of Pretoria, Pretoria 0002, South Africa
2
School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio FI-70210, Finland
3
LC-MS Metabolomics Center, Biocentre, Kuopio, Kuopio FI-70210, Finland
4
School of Natural Resources, University of Missouri, Columbia, MO 65211, USA
5
College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, India
*
Author to whom correspondence should be addressed.
Academic Editor: Isabel Ferreira
Molecules 2019, 24(11), 2191; https://doi.org/10.3390/molecules24112191
Received: 11 May 2019 / Revised: 30 May 2019 / Accepted: 6 June 2019 / Published: 11 June 2019
(This article belongs to the Collection Bioactive Compounds)
Verbascoside is found in many medicinal plant families such as Verbenaceae. Important biological activities have been ascribed to verbascoside. Investigated in this study is the potential of verbascoside as an adjuvant during tuberculosis treatment. The present study reports on the in vitro metabolism in human hepatic microsomes and cytosol incubations as well as the presence and quantity of verbascoside within Lippia scaberrima. Additionally, studied are the inhibitory properties on human hepatic CYP enzymes together with antioxidant and cytotoxic properties. The results yielded no metabolites in the hydrolysis or cytochrome P450 (CYP) oxidation incubations. However, five different methylated conjugates of verbascoside could be found in S-adenosylmethionine incubation, three different sulphate conjugates with 3′-phosphoadenosine 5′-phosphosulfate (PAPS) incubation with human liver samples, and very low levels of glucuronide metabolites after incubation with recombinant human uridine 5’-diphospho-glucuronosyltransferase (UGT) 1A7, UGT1A8, and UGT1A10. Additionally, verbascoside showed weak inhibitory potency against CYP1A2 and CYP1B1 with IC50 values of 83 µM and 86 µM, respectively. Potent antioxidant and low cytotoxic potential were observed. Based on these data, verbascoside does not possess any clinically relevant CYP-mediated interaction potential, but it has effective biological activity. Therefore, verbascoside could be considered as a lead compound for further drug development and as an adjuvant during tuberculosis treatment. View Full-Text
Keywords: cytochrome P450; verbascoside; metabolism; antioxidant; cytotoxicity; liver cytochrome P450; verbascoside; metabolism; antioxidant; cytotoxicity; liver
Show Figures

Graphical abstract

MDPI and ACS Style

Reid, A.-M.; Juvonen, R.; Huuskonen, P.; Lehtonen, M.; Pasanen, M.; Lall, N. In Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes. Molecules 2019, 24, 2191.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop